SE0014428512
SE0014428512
Surgical Science Sweden AB
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 992.344.000 | 884.087.000 | 12.2% |
| Cost of Revenue | 334.668.000 | 286.189.000 | 16.9% |
| Gross Profit | 657.676.000 | 597.898.000 | 10.0% |
| 588.793.000 | 453.576.000 | 29.8% | |
| Operating Income | 68.883.000 | 144.322.000 | 52.3% |
| Pretax Income | 100.137.000 | 158.093.000 | 36.7% |
| Net Income Common Stockholders | 66.818.000 | 131.646.000 | 49.2% |
| -- | -- | -- | |
| -- | -- | -- |